IRadimed Corporation (IRMD) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 92.2 |
| Open | 91.2 |
| Day High | 92.54 |
| Day Low | 90.18 |
| 52-Week High | 107.9 |
| 52-Week Low | 55.11 |
| Volume | 91,380 |
| Average Volume | 124,912 |
| Market Cap | 1.17B |
| PE | 50.1 |
| EPS | 1.83 |
| Moving Average 50 Days | 90.15 |
| Moving Average 200 Days | 90.14 |
| Change | -0.51 |
IRADIMED CORPORATION to Hold Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 10, 2026
GlobeNewswire Inc.
Feb 04, 2026 9:05 PM GMT
ORLANDO, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 fourth quarter and full year financial results before the market opens on Tuesday, February 10, 2026. Iradim
IRADIMED Announces Special Cash Dividend of $0.50 Per Share
GlobeNewswire Inc.
Dec 08, 2025 1:30 PM GMT
ORLANDO, Fla., Dec. 08, 2025 (GLOBE NEWSWIRE) -- iRadimed Corporation (the “Company”) (NASDAQ: IRMD), announced that its Board of Directors (the “Board”) approved a special cash dividend of $0.50 per share of the Company’s outstanding common stock.
IRADIMED CORPORATION Named to TIME's List of America's Growth Leaders for 2026
GlobeNewswire Inc.
Nov 10, 2025 2:00 PM GMT
Recognized for Exceptional Revenue Growth, Financial Stability, and Stock PerformanceORLANDO, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in developing innovative magnetic resonance imaging (MRI)-compatible